![]() ![]() Molecular Diagnostics Market Characteristicsģ. Hain Lifescience GmbH is an infectious disease molecular diagnostics (MDx) specialist and provides solutions for detecting microbial and viral pathogens, antibiotic resistance testing, and human genetic diseases.Ģ. This acquisition will help Bruker to expand its presence in attractive microbiology and virology infectious disease MDx markets, and add tuberculosis and mycobacteria testing, virology and in human genetics MDx, and a pipeline for multiplex syndromic panel testing to its portfolio. In August 2018, Bruker Corporation, an American based manufacturer of scientific instruments for molecular and materials research announced plans to acquire majority stake in Hain Lifescience GmbH for undisclosed amount. The growing research in proteomics and genomics will help develop more advanced molecular diagnostic techniques in the forecast period. Following the trend, Genome Canada, a source of funding for genomics and proteomics, announced plans to invest $16 million between the period April 2015 and March 2017. The advances in genomics and proteomics is a key trend driving the growth of the molecular diagnostics market. The complexity involved in regulatory and legal requirements that applies to molecular diagnostics tests is expected to limit the growth of the molecular diagnostics market. The increasing prevalence of cancer globally increases the demand for molecular diagnostic tests for effective diagnosis of cancer over the coming years, thereby contributing to the growth of the market. It places the market within the context of the wider molecular diagnostics market, and compares it with other markets. ![]() ![]() It traces the market's historic and forecast market growth by geography. This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. Major players in the market are Abbott, bioMerieux, Danaher Corporation, Grifols, Hologic, Novartis, QIAGEN, Siemens Healthcare, Becton, Dickinson and Company. North America was the largest region in 2019. The global molecular diagnostics market was worth $8.62 billion in 2019. DUBLIN-( BUSINESS WIRE)-The "Molecular Diagnostics Market Global Report 2020-2030" report has been added to 's offering. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |